Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Christopher F. Bell, Anna D. Coutinho, Eileen Farrelly, Tasneem Lokhandwala & Pamela Landsman-Blumberg. (2018) Clinical and economic outcomes associated with the use of fluticasone propionate 250 mcg and salmeterol 50 mcg combination versus tiotropium bromide 18 mcg as initial maintenance treatment for chronic obstructive pulmonary disease in managed care. Journal of Medical Economics 21:6, pages 629-638.
Read now
Read now
M. H. Roberts, M. E. Borrego, A. A. Kharat, P. L. Marshik & D. W. Mapel. (2016) Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 167-192.
Read now
Read now
Timothy E Albertson, Richart Harper, Susan Murin & Christian Sandrock. (2015) Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol. Patient Preference and Adherence 9, pages 235-242.
Read now
Read now
Rachel Halpern, Christine L Baker, Jun Su, Kimberly B Woodruff, Ryne Paulose-Ram, Victoria Porter & Hemal Shah. (2011) Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease. Patient Preference and Adherence 5, pages 375-388.
Read now
Read now
Christopher M Blanchette, Melissa H Roberts, Hans Petersen, Anand A Dalal & Douglas W Mapel. (2011) Economic burden of chronic bronchitis in the United States: a retrospective case-control study. International Journal of Chronic Obstructive Pulmonary Disease 6, pages 73-81.
Read now
Read now
Anand A Dalal, Melissa H Roberts, Hans V Petersen, Christopher M Blanchette & Douglas W Mapel. (2011) Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 6, pages 13-22.
Read now
Read now
Zhun Cao, Kelly H. Zou, Christine L. Baker, Jun Su, Ryne Paulose-Ram, Emily Durden, Nianwen Shi & Hemal Shah. (2011) Respiratory-related medical expenditure and inpatient utilisation among COPD patients receiving long-acting bronchodilator therapy. Journal of Medical Economics 14:2, pages 147-158.
Read now
Read now
Meaghan St. Charles, Christopher M. Blanchette, Harris Silver, Danielle Lavallee, Anand A. Dalal & Douglas Mapel. (2010) Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Current Medical Research and Opinion 26:10, pages 2421-2429.
Read now
Read now
Barbara P Yawn, Ibrahim Raphiou, Judith S Hurley & Anand A Dalal. (2010) The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease 5, pages 165-178.
Read now
Read now
Anand A Dalal, Meaghan St Charles, Hans V Petersen, Melissa H Roberts, Christopher M Blanchette & Kathy Manavi-Zieverink. (2010) Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 5, pages 179-187.
Read now
Read now
Articles from other publishers (7)
Melissa H. Roberts, Douglas W. Mapel, Matthew E. Borrego, Dennis W. Raisch, Larry Georgopoulos & David van der Goes. (2015) Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods. Drugs - Real World Outcomes 2:2, pages 163-175.
Crossref
Crossref
Steven Simoens. (2013) Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review. Journal of Evaluation in Clinical Practice 19:6, pages 1004-1011.
Crossref
Crossref
Shelagh M. Szabo, Katherine L. Gooch, Ellen E. Korol, Pamela Bradt, Pamela Vo & Adrian R. Levy. (2012) Respiratory Distress Syndrome at Birth Is a Risk Factor for Hospitalization for Lower Respiratory Tract Infections in Infancy. Pediatric Infectious Disease Journal 31:12, pages 1245-1251.
Crossref
Crossref
Richard H. Stanford, Christopher M. Blanchette, Melissa H. Roberts, Hans Petersen & Anne L. Fuhlbrigge. (2012) Effect of Combination Fluticasone Propionate and Salmeterol or Inhaled Corticosteroids on Asthma-Related Outcomes in a Medicare-Eligible Population. The American Journal of Geriatric Pharmacotherapy 10:6, pages 343-351.
Crossref
Crossref
Linnea A. Polgreen & John M. Brooks. (2012) Estimating Incremental Costs with Skew. Applied Health Economics and Health Policy 10:5, pages 319-329.
Crossref
Crossref
Linda Simoni-Wastila, Yu-Jung Wei, Jingjing Qian, Ilene H. Zuckerman, Bruce Stuart, Thomas Shaffer, Anand A. Dalal & Lynda Bryant-Comstock. (2012) Association of Chronic Obstructive Pulmonary Disease Maintenance Medication Adherence With All-Cause Hospitalization and Spending in a Medicare Population. The American Journal of Geriatric Pharmacotherapy 10:3, pages 201-210.
Crossref
Crossref
Linda Simoni-Wastila, Christopher M. Blanchette, Jingjing Qian, Hui-wen Keri Yang, Lirong Zhao, Ilene H. Zuckerman, Grace H. Pak, Harris Silver & Anand A. Dalal. (2009) Burden of chronic obstructive pulmonary disease in medicare beneficiaries residing in long-term care facilities. The American Journal of Geriatric Pharmacotherapy 7:5, pages 262-270.
Crossref
Crossref